Medications

FDA still skeptical of ALS drug ahead of high-stakes meeting

Federal health regulators remain unconvinced about the benefits of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, even as they prepare to give its drugmaker a rare second opportunity ...

Other

Experimental stroke therapy helps Illinois senator

(AP) -- Good luck and experimental therapy may have helped U.S. Sen. Mark Kirk recover more extensively than he would have with standard care after he suffered a stroke in January.

Addiction

Smoking: Quitting is tough for teens, too

Abstinence from smoking seems to affect teens differently than adults in a couple ways, but a new study provides evidence that most of the psychological difficulties of quitting are as strong for relatively new, young smokers ...

page 4 from 6